CONTACT
DIAGNOSTICS
ABOUT ABBOTT
i-STAT Registration
i-STAT Login
CUSTOMER HOME
PARTNERS HOME
DISTRIBUTION HOME
EMPLOYEES HOME
REPAIR MANUAL
COMPLETE PROFILE
DASHBOARD
My Account

Global Point of Care

Panbio™ COVID-19/Flu A&B Panel (NASAL)

KNOW IF IT'S COVID-19 OR INFLUENZA SO YOU CAN ACT WITH CONFIDENCE

Common symptoms of COVID-19 and flu make presumptive diagnosis challenging.1 Rapid, accurate testing is a first step toward early diagnosis and treatment. The window to start critical treatment is limited, so act quickly with one test for timely differential diagnosis. Act with confidence using the Panbio™ COVID-19/Flu A&B Panel (Nasal) test, for reliable results in 15 minutes at the point of care.

Product not available in all countries. Not approved for sale in the USA.

Contact Sales
Contact Sales
Technical Support
Technical Support
Panbio COVID-19/Flu A&B Rapid Panel
Chapter Navigation
Benefits

Easy to Use

  • Uses a single, patient-friendly nasal swab
  • Simplified workflow with pre-filled buffer tube
  • Suitable for ages 1 and above

Reliable

  • Demonstrated clinical performance using fresh samples
  • Meets IVDR requirements

15-minute results

  • Prescribe appropriate treatments during the patient visit 
  • Act quickly to help prevent the spread of illness
Helpful Documents

PRODUCT DOCUMENTS

SPECIFICATIONS

  • For patients presenting symptoms or suspected of current COVID-19, Flu A and/or B infection 
  • Results in 15 minutes
  • Nasal swab
  • Pre-filled buffer extraction tubes
  • Storage: 2°C–30°C
  • Kit Contents:
    - Test devices
    - Extraction buffer tubes
    - Nozzle caps
    - Sterilized nasal swabs for specimen collection
    - Tube rack
    - Instructions for Use with Quick Reference Guide
  • CE Mark

PRODUCT CODE

Product CodesCode
Panbio™ COVID-19/Flu A&B Panel (Nasal) 10 test kit62FK31
Panbio™ COVID-19/Flu A&B Panel (Nasal) 20 test kit62FK41
VIDEOS
Panbio™  COVID-19 COVID-19/Flu A&B Panel (Nasal) Demo Video

Panbio™  COVID-19 COVID-19/Flu A&B Panel (Nasal) Demo Video

Watch a demonstration of the procedure.

Panbio™  COVID-19 COVID-19/Flu A&B Nasal Differentiation Video

Panbio™  COVID-19 COVID-19/Flu A&B Nasal Differentiation Video

Watch a live demonstration of the procedure

Reference

  1. CDC. Similarities and Differences between Flu and COVID-19 https://www.cdc.gov/flu/symptoms/flu-vs-covid19.htm. Reviewed September 28, 2022. Accessed January 4, 2024.


Registered under Act 737. MDA registration number: IVDC5896024-166890 (Panbio™ Covid-19/Flu A&B Panel (Nasal); 62FK31, 62FK41).

A Leader In Rapid Point-Of-Care Diagnostics.

PRODUCT CATALOG
SOLUTIONS
CUSTOMER STORIES
VIEWPOINTS
CONTACT US
PRODUCT DOCUMENT SEARCH
PRODUCT DEMOS
INTEREST-BASED ADS

©2026 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement.

Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.

Abbott - A Leader in Rapid Point-of-Care Diagnostics.